Journal Home
Search for

Volume 48, Issue 5, Pages 1092-1100.e2 (November 2008)


View previous. 9 of 70 View next.

National outcomes for the treatment of ruptured abdominal aortic aneurysm: Comparison of open versus endovascular repairs

Presented at the Society for Vascular Surgery Annual Meeting, Baltimore, Md, Jun 7-10, 2007.

Natalia Egorova, PhDa, Jeannine Giacovelli, MDab, Giampaolo Greco, PhDa, Annetine Gelijns, PhDa, Craig K. Kent, MDb, James F. McKinsey, MDbCorresponding Author Informationemail address

Received 3 June 2008; accepted 18 June 2008.

Objectives

Endovascular repair (EVAR) of ruptured abdominal aortic aneurysms (rAAA) has been shown to acutely decrease procedural mortality compared to open aortic repair (OAR). However, little is known about the effect of choice of procedure; EVAR vs OAR, or the impact of physician and institution volume on long-term survival and outcome.

Methods

Patients hospitalized with rAAA who underwent either OAR or EVAR, were derived from the Medicare inpatient dataset (1995-2004) using ICD9 codes. We evaluated long-term survival after OAR and EVAR in the entire fee-for-service Medicare population, and then in patients matched by propensity score to create two similar cohorts for comparison with Kaplan-Meier analysis. Annual surgeon and hospital volumes of EVAR (elective and ruptured), OAR (elective and ruptured), and rAAA (EVAR and OAR) were divided into quintiles to determine if increasing volumes correlate with decreasing mortality. Predictors of survival were determined by Cox modeling.

Results

A total of 43,033 Medicare beneficiaries had rAAA repair: 41,969 had OAR and 1,064 had EVAR. The proportions of patients with diabetes, hypertension, cardiovascular, cerebrovascular, renal disease, hyperlipidemia, and cancer were statistically higher in the EVAR than in the OAR group, whereas lower extremity vascular disease was higher in the OAR group. The initial evaluation of EVAR vs OAR, prior to propensity matching, showed no statistical advantage in EVAR-survival after 90 days. The survival analysis of patients matched by propensity score showed a benefit of EVAR over OAR that persisted throughout the 4 years of follow-up (P = .0042). Perioperative and long-term survival after rAAA repair correlated with increasing annual surgeon and hospital volume in OAR and EVAR and also with rAAA experience. EVAR repair had a protective effect (HR = 0.857, P = .0061) on long-term survival controlling for comorbidities, demographics, and hospital and surgeon volume.

Conclusion

When EVAR and OAR patients are compared using a reliable statistical technique such as propensity analysis, the perioperative survival advantage of rAAA repaired endovascularly is maintained over the long term. Institutional experience with rAAA is critical for survival after either OAR or EVAR.

a International Center for Innovation and Outcomes Research (InCHOIR) Columbia University, New York, NY

b New York-Presbyterian Hospital, The University Hospital of Columbia and Cornell, New York, NY

Corresponding Author InformationReprint requests: Dr James F. McKinsey, Columbia University, Department of Surgery; Division of Vascular Surgery, 161 Fort Washington Avenue, Suite 648, New York, NY 10032

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

 Natalia Egorova and Jeannine Giacovelli are co-first authors.

PII: S0741-5214(08)01029-X

doi:10.1016/j.jvs.2008.06.036


View previous. 9 of 70 View next.